Hims & Hers Q1 2022 Earnings Report
Key Takeaways
Hims & Hers Health, Inc. reported strong first-quarter 2022 results, with revenue reaching $101.3 million, up 94% year-over-year. The company also experienced its largest-ever quarterly gain in member subscriptions, increasing by 101,000 to a total of 710,000. The company raises full year 2022 revenue guidance to the range of $410.0 million to $425.0 million and maintains Adjusted EBITDA guidance in the range of $(30.0) million to $(20.0) million
Revenue for Q1 2022 reached $101.3 million, a 94% increase year-over-year.
The company added 101,000 new subscriptions in Q1 2022.
Hims & Hers ended Q1 2022 with 710,000 subscriptions, up 82% year-over-year.
Full year 2022 revenue guidance raised to $410 - $425 million.
Hims & Hers
Hims & Hers
Hims & Hers Revenue by Segment
Forward Guidance
For the second quarter 2022, we expect: Revenue to be in the range of $103 million to $106 million. Adjusted EBITDA to be in the range of $(9) million to $(7) million, which would reflect an Adjusted EBITDA margin in the range of (9)% to (7)%. For the full year 2022, we expect: Revenue to be in the range of $410 million to $425 million. Adjusted EBITDA to be in the range of $(30) million to $(20) million, which would reflect an Adjusted EBITDA margin in the range of (7)% to (5)%.
Positive Outlook
- Revenue to be in the range of $103 million to $106 million for Q2 2022
- Adjusted EBITDA to be in the range of $(9) million to $(7) million for Q2 2022
- Revenue to be in the range of $410 million to $425 million for FY 2022
- Adjusted EBITDA to be in the range of $(30) million to $(20) million for FY 2022
Revenue & Expenses
Visualization of income flow from segment revenue to net income